Moleculin Biotech, Inc. (MBRX) vs Theriva Biologics, Inc. (TOVX)
Moleculin Biotech, Inc. and Theriva Biologics, Inc. are both Biotechnology companies. Moleculin Biotech, Inc. and Theriva Biologics, Inc. are of similar size ($11.2M and $10.6M). Moleculin Biotech, Inc. trades at the lower P/E: 0.1× against 0.2×. Across the 11 metrics below, Theriva Biologics, Inc. leads on 6 and Moleculin Biotech, Inc. on 5.
Valuation
Profitability
| Metric | MBRX | TOVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,471.05%) | (115.11%) | (57.72%) |
| Return on assets | (152.41%) | (37.14%) | (49.22%) |
| Return on invested capital | (417.27%) | (301.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack